L302-1313 Screening compound: 1-cyclopropanecarbonyl-N-(2-ethyl-6-methylphenyl)-3,3-dimethyl-2,3-dihydro-1H-indole-5-sulfonamide

L302-1313 Screening compound: 1-cyclopropanecarbonyl-N-(2-ethyl-6-methylphenyl)-3,3-dimethyl-2,3-dihydro-1H-indole-5-sulfonamide
L302-1313 Screening compound: 1-cyclopropanecarbonyl-N-(2-ethyl-6-methylphenyl)-3,3-dimethyl-2,3-dihydro-1H-indole-5-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L302-1313
1-cyclopropanecarbonyl-N-(2-ethyl-6-methylphenyl)-3,3-dimethyl-2,3-dihydro-1H-indole-5-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L302-1313

Molecular Formula

C23H28N2O3S (C23 H28 N2 O3 S)

Compound Name

1-cyclopropanecarbonyl-N-(2-ethyl-6-methylphenyl)-3,3-dimethyl-2,3-dihydro-1H-indole-5-sulfonamide

IUPAC name

1-cyclopropanecarbonyl-N-(2-ethyl-6-methylphenyl)-33-dimethyl-23-dihydro-1H-indole-5-sulfonamide

SMILES

CCc(cccc1C)c1NS(c(cc1)cc(C(C)(C)C2)c1N2C(C1CC1)=O)(=O)=O

InChI

InChI=1S/C23H28N2O3S/c1-5-16-8-6-7-15(2)21(16)24-29(27,28)18-11-12-20-19(13-18)23(3,4)14-25(20)22(26)17-9-10-17/h6-8,11-13,17,24H,5,9-10,14H2,1-4H3

InChI Key

XHUSREHJPNKZGH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27242957

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

412.55

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.786

Distribution Coefficient, logD

4.783

Water Solubility, LogSw

-4.51

Polar Surface Area

55.628

Acid Dissociation Constant (pKa)

9.65

Base Dissociation Constant (pKb)

-2.37

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

43.50

L302-1313 in Drug Discovery

Included in Screening Libraries

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L302-1313 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L302-1313?
Check Price and Availability of L302-1313, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L302-1313 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L302-1313
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L302-1313
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L302-1313 available by request